JACOBS LEVY EQUITY MANAGEMENT, INC

Position in KURA — Kura Oncology, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in KURA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,896,138

-$16,115,901 QoQ

Shares Held

602,231

-70.2% QoQ

Ownership

0.678%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 60.540722745923084.ToString("F0")% Shared 0.ToString("F0")% None 39.45927725407692.ToString("F0")%

Healthcare · as of Mar 31, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $705,903,019 across 86 Biotechnology names. KURA ranks #20 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	214,160	$165,468,582
2	INCY	Incyte Corp	1,717,978	$161,696,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	212,204	$70,211,937
4	HALO	Halozyme Therapeutics, Inc.	789,429	$51,020,796
5	RARE	Ultragenyx Pharmaceutical Inc.	1,431,071	$29,980,937
6	EXEL	Exelixis, Inc.	425,982	$18,270,367
7	AUPH	Aurinia Pharmaceuticals Inc.	1,097,189	$16,260,340
8	ARVN	Arvinas, Inc.	1,441,521	$15,280,122

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,896,138	602,231	-70.2%	Shares	Sole	2026-05-15
2025-12-31	$21,012,039	2,022,333	-9.1%	Shares	Sole	2026-02-13
2025-09-30	$19,687,621	2,224,590	+101.6%	Shares	Sole	2025-11-17
2025-06-30	$6,366,398	1,103,362	-28.5%	Shares	Sole	2025-08-14
2025-03-31	$10,191,145	1,544,113	+57.9%	Shares	Sole	2025-05-15
2024-12-31	$8,517,683	977,920	+5455.7%	Shares	Sole	2025-02-14
2020-03-31	$175,139	17,602	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.